These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19050397)

  • 21. CCR7 and its ligands: balancing immunity and tolerance.
    Förster R; Davalos-Misslitz AC; Rot A
    Nat Rev Immunol; 2008 May; 8(5):362-71. PubMed ID: 18379575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High frequency and proliferation of CD4+ FOXP3+ Treg in HIV-1-infected patients with low CD4 counts.
    Bi X; Suzuki Y; Gatanaga H; Oka S
    Eur J Immunol; 2009 Jan; 39(1):301-9. PubMed ID: 19089812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failure.
    Yndestad A; Finsen AV; Ueland T; Husberg C; Dahl CP; Øie E; Vinge LE; Sjaastad I; Sandanger Ø; Ranheim T; Dickstein K; Kjekshus J; Damås JK; Fiane AE; Hilfiker-Kleiner D; Lipp M; Gullestad L; Christensen G; Aukrust P
    PLoS One; 2012; 7(3):e33038. PubMed ID: 22427939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCR7-CCL19/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination.
    Song JH; Kim JI; Kwon HJ; Shim DH; Parajuli N; Cuburu N; Czerkinsky C; Kweon MN
    J Immunol; 2009 Jun; 182(11):6851-60. PubMed ID: 19454681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells.
    Halvorsen B; Dahl TB; Smedbakken LM; Singh A; Michelsen AE; Skjelland M; Krohg-Sørensen K; Russell D; Höpken UE; Lipp M; Damås JK; Holm S; Yndestad A; Biessen EA; Aukrust P
    Cardiovasc Res; 2014 Apr; 102(1):148-56. PubMed ID: 24518141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric human immunodeficiency virus infection and circulating IgD+ memory B cells.
    Jacobsen MC; Thiébaut R; Fisher C; Sefe D; Clapson M; Klein N; Baxendale HE
    J Infect Dis; 2008 Aug; 198(4):481-5. PubMed ID: 18582200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation.
    Bonora S; Nicastri E; Calcagno A; Gonzalez de Requena D; D'Ettorre G; Sarmati L; Palmisano L; Vullo V; Di Perri G; Andreoni M
    J Med Virol; 2009 Mar; 81(3):400-5. PubMed ID: 19152404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails.
    Brandum EP; Jørgensen AS; Calvo MB; Spiess K; Peterson FC; Yang Z; Volkman BF; Veldkamp CT; Rosenkilde MM; Goth CK; Hjortø GM
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions.
    Krumbholz M; Theil D; Steinmeyer F; Cepok S; Hemmer B; Hofbauer M; Farina C; Derfuss T; Junker A; Arzberger T; Sinicina I; Hartle C; Newcombe J; Hohlfeld R; Meinl E
    J Neuroimmunol; 2007 Oct; 190(1-2):72-9. PubMed ID: 17825430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCR7-specific migration to CCL19 and CCL21 is induced by PGE(2) stimulation in human monocytes: Involvement of EP(2)/EP(4) receptors activation.
    Côté SC; Pasvanis S; Bounou S; Dumais N
    Mol Immunol; 2009 Aug; 46(13):2682-93. PubMed ID: 19545899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation.
    Fevang B; Yndestad A; Damås JK; Halvorsen B; Holm AM; Beiske K; Aukrust P; Frøland SS
    Clin Exp Immunol; 2009 Nov; 158(2):237-45. PubMed ID: 19747210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCR7 deficiency on dendritic cells enhances fungal clearance in a murine model of pulmonary invasive aspergillosis.
    Hartigan AJ; Westwick J; Jarai G; Hogaboam CM
    J Immunol; 2009 Oct; 183(8):5171-9. PubMed ID: 19783686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CMV DNA levels and CMV gB subtypes in ART-naive HAART-treated patients: a 2-year follow-up study in The Netherlands.
    Goossens VJ; Wolffs PF; van Loo IH; Bruggeman CA; Verbon A
    AIDS; 2009 Jul; 23(11):1425-9. PubMed ID: 19531930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients.
    Landman R; Damond F; Gerbe J; Brun-Vezinet F; Yeni P; Matheron S
    AIDS; 2009 Jan; 23(3):426-8. PubMed ID: 19114866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between genotypic sensitivity score and treatment outcomes in late stage HIV disease after supervised HAART.
    Castor D; Vlahov D; Hoover DR; Berkman A; Wu YF; Zeller B; Brechtl J; Hammer SM
    J Med Virol; 2009 Aug; 81(8):1323-35. PubMed ID: 19551816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.
    Simonelli C; Tedeschi R; Gloghini A; Talamini R; Bortolin MT; Berretta M; Spina M; Morassut S; Vaccher E; De Paoli P; Carbone A; Tirelli U
    J Med Virol; 2009 May; 81(5):888-96. PubMed ID: 19319955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.
    Landman R; Capitant C; Descamps D; Chazallon C; Peytavin G; Katlama C; Pialoux G; Bentata M; Brun-Vézinet F; Aboulker JP; Yéni P;
    J Antimicrob Chemother; 2009 Jul; 64(1):118-25. PubMed ID: 19420019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brazilian HIV-infected population: assessment of the needs of endodontic treatment in the post-highly active antiretroviral therapy era.
    de Brito LC; da Rosa MA; Lopes VS; e Ferreira EF; Vieira LQ; Sobrinho AP
    J Endod; 2009 Sep; 35(9):1178-81. PubMed ID: 19720212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transferring the C-terminus of the chemokine CCL21 to CCL19 confers enhanced heparin binding.
    Barmore AJ; Castex SM; Gouletas BA; Griffith AJ; Metz SW; Muelder NG; Populin MJ; Sackett DM; Schuster AM; Veldkamp CT
    Biochem Biophys Res Commun; 2016 Sep; 477(4):602-606. PubMed ID: 27338641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Markov modelling of HIV infection evolution in the HAART era.
    Binquet C; Le Teuff G; Abrahamovicz M; Mahboubi A; Yazdanpanah Y; Rey D; Rabaud C; Chirouze C; Berger JL; Faller JP; Chavanet P; Quantin C; Piroth L;
    Epidemiol Infect; 2009 Sep; 137(9):1272-82. PubMed ID: 19134234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.